Sixty-two percent of health system executives support Amazon's growing presence in the medical supply sector and nearly the same amount said the company could successfully deliver supplies faster and at a lower price, according to a new survey.
Generic-drug manufacturers, which source most of their active ingredients from China and India, could be hit the hardest by President Donald Trump's proposed tariffs, experts said.
The test doesn't detect concussions and the approval won't immediately change how patients with suspected concussions are treated. But it allows Banyan Biomarkers to commercialize its test, giving the company an early lead in the race to find a way to diagnose concussions.
Tired of paying intermediaries' price markups, some providers are getting better deals elsewhere.
Norman Regional Health System is bundling its equipment purchasing to reduce costs and improve care.
The economic term for what's happening in retailing is disintermediation—the removal of middlemen from a supply chain or a series of transactions.
The constant, complicated stream of administrative documents flooding healthcare providers' back offices involved can pose significant financial risks, but new software aims to streamline the process.
The best healthcare providers don't need marketing tools to attract patients, because they have data. And no amount of marketing can fix bad quality.
Given the critical role that supply chain plays in hospital operations, it is essential to understand how hospital stakeholders gauge its importance and how it impacts them on a daily basis.
The 10-hospital Kentucky Health Collaborative used its first year of operations to build trust among CEOs and tackle a few group purchasing projects. Now, it will take on population health.
The Charlotte, N.C.-based group purchasing organization and performance improvement company reported higher profits, driven by rising supply chain revenue from its group purchasing business, including its recent Innovatix and Essensa acquisitions.
A new study raises questions about how the drug industry funnels payments to physicians and the impact of those payments on outcomes and costs.